Literature DB >> 32383599

Metadynamics as a Postprocessing Method for Virtual Screening with Application to the Pseudokinase Domain of JAK2.

Kara J Cutrona1, Ana S Newton1, Stefan G Krimmer1, Julian Tirado-Rives1, William L Jorgensen1.   

Abstract

With standard scoring methods, top-ranked compounds from virtual screening by docking often turn out to be inactive. For this reason, metadynamics, a method used to sample rare events, was studied to further evaluate docking poses with the aim of reducing false positives. Specifically, virtual screening was performed with Glide SP to seek potential molecules to bind to the ATP site in the pseudokinase domain of JAK2 kinase, and promising compounds were selected from the top-ranked 1000 based on visualization. Rescoring with Glide XP, GOLD, and MM/GBSA was unable to differentiate well between active and inactive compounds. Metadynamics was then used to gauge the relative binding affinity from the required time or the potential of mean force needed to dissociate the ligand from the bound complex. With consideration of previously known binders of varying affinities, metadynamics was able to differentiate between the most active compounds and inactive or weakly active ones, and it could identify correctly most of the selected virtual screening compounds as false positives. Thus, metadynamics has the potential to be a viable postprocessing method for virtual screening, minimizing the expense of buying or synthesizing inactive compounds.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32383599      PMCID: PMC7927942          DOI: 10.1021/acs.jcim.0c00276

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  56 in total

1.  Single-molecule pulling simulations can discern active from inactive enzyme inhibitors.

Authors:  Francesco Colizzi; Remo Perozzo; Leonardo Scapozza; Maurizio Recanatini; Andrea Cavalli
Journal:  J Am Chem Soc       Date:  2010-06-02       Impact factor: 15.419

2.  Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoring.

Authors:  Gabriela Barreiro; Cristiano R W Guimarães; Ivan Tubert-Brohman; Theresa M Lyons; Julian Tirado-Rives; William L Jorgensen
Journal:  J Chem Inf Model       Date:  2007-10-20       Impact factor: 4.956

3.  Empirical scoring functions. II. The testing of an empirical scoring function for the prediction of ligand-receptor binding affinities and the use of Bayesian regression to improve the quality of the model.

Authors:  C W Murray; T R Auton; M D Eldridge
Journal:  J Comput Aided Mol Des       Date:  1998-09       Impact factor: 3.686

4.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

5.  Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes.

Authors:  M D Eldridge; C W Murray; T R Auton; G V Paolini; R P Mee
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

6.  End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design.

Authors:  Ercheng Wang; Huiyong Sun; Junmei Wang; Zhe Wang; Hui Liu; John Z H Zhang; Tingjun Hou
Journal:  Chem Rev       Date:  2019-06-24       Impact factor: 60.622

7.  Molecular recognition using a binary genetic search algorithm.

Authors:  A W Payne; R C Glen
Journal:  J Mol Graph       Date:  1993-06

8.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

Authors:  E Joanna Baxter; Linda M Scott; Peter J Campbell; Clare East; Nasios Fourouclas; Soheila Swanton; George S Vassiliou; Anthony J Bench; Elaine M Boyd; Natasha Curtin; Mike A Scott; Wendy N Erber; Anthony R Green
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

9.  1.14*CM1A-LBCC: Localized Bond-Charge Corrected CM1A Charges for Condensed-Phase Simulations.

Authors:  Leela S Dodda; Jonah Z Vilseck; Julian Tirado-Rives; William L Jorgensen
Journal:  J Phys Chem B       Date:  2017-03-02       Impact factor: 2.991

Review 10.  Rethinking JAK2 inhibition: towards novel strategies of more specific and versatile Janus kinase inhibition.

Authors:  E Leroy; S N Constantinescu
Journal:  Leukemia       Date:  2017-01-25       Impact factor: 11.528

View more
  3 in total

1.  Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity.

Authors:  Anat Levit Kaplan; Danielle N Confair; Kuglae Kim; Ximena Barros-Álvarez; Ramona M Rodriguiz; Ying Yang; Oh Sang Kweon; Tao Che; John D McCorvy; David N Kamber; James P Phelan; Luan Carvalho Martins; Vladimir M Pogorelov; Jeffrey F DiBerto; Samuel T Slocum; Xi-Ping Huang; Jain Manish Kumar; Michael J Robertson; Ouliana Panova; Alpay B Seven; Autumn Q Wetsel; William C Wetsel; John J Irwin; Georgios Skiniotis; Brian K Shoichet; Bryan L Roth; Jonathan A Ellman
Journal:  Nature       Date:  2022-09-28       Impact factor: 69.504

2.  Conversion of a False Virtual Screen Hit into Selective JAK2 JH2 Domain Binders Using Convergent Design Strategies.

Authors:  Sean P Henry; Maria-Elena Liosi; Joseph A Ippolito; Kara J Cutrona; Stefan G Krimmer; Ana S Newton; Joseph Schlessinger; William L Jorgensen
Journal:  ACS Med Chem Lett       Date:  2022-04-21       Impact factor: 4.632

3.  Hydrogen bonding penalty used for virtual screening to discover potent inhibitors for Papain-Like cysteine proteases of SARS-CoV-2.

Authors:  Guangjian Zhao; Xiaochun Liu; Suyun Wang; Zhongyue Bai; Siyu Zhang; Yifan Wang; Haibo Yu; Ximing Xu
Journal:  Chem Biol Drug Des       Date:  2022-07-26       Impact factor: 2.873

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.